- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-18/25 R: Order of the President of the General Court of 4 April 2025 – Apellis Europe v Commission (Interim relief – Medicinal products for human use – Marketing authorisation for Syfovre – Pegcetacoplan – Application for suspension of operation of a measure – No urgency)
ECLI:EU:UNKNOWN:62025TB0018
62025TB0018
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2025/2902
(Case T-18/25 R)
(Interim relief - Medicinal products for human use - Marketing authorisation for Syfovre - Pegcetacoplan - Application for suspension of operation of a measure - No urgency)
(C/2025/2902)
Language of the case: English
Parties
Applicant: Apellis Europe BV (Amsterdam, Netherlands) (represented by: A. Koyuncu, V. Sturla and M. Aretz, lawyers)
Defendant: European Commission (represented by: E. Mathieu and A. Spina, acting as Agents)
Re:
By its application under Articles 278 and 279 TFEU, the applicant seeks the suspension of the operation of Commission Implementing Decision C(2024) 9160 final of 16 December 2024 refusing marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for the medicinal product for human use ‘Syfovre – Pegcetacoplan’.
Operative part of the order
The application for interim measures is dismissed.
The costs are reserved.
—
ELI: http://data.europa.eu/eli/C/2025/2902/oj
ISSN 1977-091X (electronic edition)
—